USPTO serial 79452090
LUCHEL
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- WEATE, KIMBERLY KAY
- Law office
- TMO LAW OFFICE 139
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with LUCHEL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Anti-aging creams; anti-aging toner; anti-aging moisturizer; anti-aging cleanser; non-medicated anti-aging serum; anti-aging cream containing a retinoic ingredient not for medical purposes; concentrated skin moisturizers used as cosmetics; body and beauty care cosmetics; serums for cosmetic purposes; skin care boosters used as cosmetics; non-medicated skin care preparations; anti-wrinkle creams; cosmetic preparations for skin renewal; mask pack for cosmetic purposes; cosmetics | ACTIVE | — |
| 005 | Boosters for skin, namely skin care preparations for medical purposes; pharmaceutical preparations for skin care; hyaluronic acid for medical purposes in the form of ampoules, for use in surgery, joint inflammation, tissue regeneration and ocular pharmaceuticals; syringes sold filled with pharmaceuticals for skin care, skin regeneration, skin moisturization, aesthetic treatments, hyaluronic acids, Botulinum toxin and pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; skin patches for the transdermal delivery of pharmaceuticals, for use in in the treatment of psoriasis, acne, fungal infection and skin disorders; skin function intensifiers for medical purposes, for use in skin care, skin regeneration and skin moisturization; hyaluronic acid preparations used in skin hydration being medical fillers for soft tissue of the skin; injectable dermal fillers; pharmaceutical fillers for skin boosters used in dermatology, for use in for skin care, skin regeneration and skin moisturization; solutions for dermatological use | ACTIVE | — |
| 010 | Syringes for medical purposes, namely, injecting skin boosters used as skin care preparations for medical purposes; syringes for medical purposes; syringes for injections, for medical purposes; skin care analyzers and light therapy equipment, namely, a black-light blue lamp unit for use in identification of a variety of skin conditions; light emitting devices, namely, lamps and LED devices for treatment of a variety of skin conditions used as medical skin care apparatus; skin moisture analyzers for medical purposes; medical apparatus for measuring skin hydration; medical apparatus for injecting fillers, namely, medical filler syringes sold empty; syringes for injection of drugs; medical apparatus and instruments for administering pharmaceuticals, namely, for monitoring patient medication dosages; syringes for injecting dermatological fillers; apparatus for the regeneration of skin for medical purposes, namely, lasers for skin treatment, electronic light therapy apparatus for the skin, electrically powered apparatus for treating skin by applying low level light and sonic vibrations to the skin; medical apparatus for skin wrinkle removal, namely, lasers, knives, needles and infrared lamps for removing skin wrinkle | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 21, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 21, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 17, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 16, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 30, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 30, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 27, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 18, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |